An open technique for ureteric implantation into the ileal loop is described. After a mean follow-up time of 2V3 years, the results of this technique were compared to those of different conventional methods. With the open technique, no ureteric dilatation was observed in the IVP films of 55 renal units. In one patient, a slight dilatation was observed on one side. In another three patients with cutaneous stomal complications, a significant ureteric dilatation was observed bilaterally. In these patients, an intestino-ureteric reflux was demonstrated roentgenologically. With the conventional techniques for uretero-intestinal anastomosis, no post-operative ureteric dilatation was noted in 19 renal units, two kidneys showed no contrast excretion, and 17 ureters became dilated post-operatively. The investigation indicates that the open method for ureteric implantation prevents secondary stricturation. A possible ureteric reflux does not cause ureteric dilatation as long as the outflow from the ileal loop is unobstructed.

Keywords:
Ureteric implantation, Ileal conduits
This content is only available via PDF.
© 1974 S. Karger AG, Basel
1974
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.